Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity

Figure 3

High ANLN expression was significantly associated with poor OS for most cancer patients. KM curves of patient OS split by high and low ANLN expressions within the following cancer types: (a) ACC, (b) BLCA, (c) CESC, (d) CHOL, (e) HNSC, (f) KICH, (g) KIRC, (h) KIRP, (i) LIHC, (j) LUAD, (k) MESO, (l) PAAD, (m) THYM, and (n) UVM.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)